Explore how the body's internal danger signals (DAMPs) drive Idiopathic Pulmonary Fibrosis, a progressive lung disease, and the latest research breakthroughs.
Discover how blocking IL-17A and activating p50NF-κB could revolutionize pulmonary fibrosis treatment by promoting the body's natural healing mechanisms.